Glipatab 10 

Presentation: Glipatab 10 tablets contain 10 mg of empagliflozin.

Indications: Glipatab 10 is indicated for:

• As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.  

• To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovasculardisease.  

  ---

Dosage and Administration:  

• The recommendeddose of Glipatab is 10 mg once daily, taken in the morning, with or without food.  
• In patients tolerating empagliflozinwho require additional glycemic control, the dose may be increased to 25 mg once daily.  
• In patients with volume depletion, correcting this condition prior to initiation of empagliflozin is recommended.  

Side Effects:The most common adverse reactions associatedwith Glipatab are:

• Urinary tract infections
• Female genital mycotic infections

Other common side effects include:

• Dehydration
• Hypotension (low blood pressure)
• Weakness
• Dizziness
• Increased thirst

Precautions:

• Glipatab is contraindicated in patients with a history of serious hypersensitivity reaction to empagliflozin or any of its ingredients, severe renal impairment, end-stage renal disease, orthose on dialysis.
• Assessment of renal function is recommended prior to initiation of Glipatab and periodically thereafter.
• Glipatab should not be initiated in patients with an eGFR less than 45 mL/min/1.73 m².
• Co-administration with diuretics may increase urine volume.
• Co-administration with insulin or insulin secretagogues may increase the risk of hypoglycemia.
• Monitoring glycemic control with urine glucose tests is not recommended as SGLT2 inhibitors increase urinary glucose excretion, leading to positive results. Alternative methods should be used.
• Monitoring glycemic control with 1,5-anhydroglucitol (1,5-AG) assay is not recommended as measurements of 1,5-AG are unreliable in patients taking SGLT2 inhibitors. Alternative methods should be used.
• The use of Glipatab during pregnancy is not recommended. It is also not recommended during breastfeeding.
• Alcohol consumption is not recommended during treatment with Glipatab due to the increased risk of altered blood sugar levels.

torage: Keep in a cool and dry place (below 30°C), protected from light and moisture. Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice. As you are in Bangladesh, always refer to local medical guidelines and consult a healthcare professional registered in Bangladesh for any health concerns or before taking any medication.